Jump to content

Atropine

From Wikipedia
atropine
type of mixture of chemical entities
Subclass ofracemate Edit
Part ofatropine biosynthetic process Edit
Get useMedication Edit
Chemical formulaC₁₇H₂₃NO₃ Edit
Active ingredient inAtropen, Isopto Atropine Edit
World Health Organisation international non-proprietary nameatropine Edit
Medical condition treatedcardiac arrest, uveitis, bradycardia, gastric ulcer Edit
Pregnancy categoryAustralian pregnancy category A, US pregnancy category C Edit
LiverTox likelihood scoreLiverTox toxicity likelihood category E Edit
Get characteristicbitterness Edit

Atropine be a tropane alkaloid den anticholinergic medication dem use to treat certain types of nerve agent den pesticide poisonings as well as sam types of slow heart rate, den to decrease saliva production during surgery.[1] E be typically given intravenously anaa by injection into a muscle.[1] Eye drops sanso be available wich be used to treat uveitis den early amblyopia.[2][3] De intravenous solution usually dey begin dey work within a minute den dey last half an hour to an hour.[4] Large doses fi be required to treat sam poisonings.[1]

Common side effects dey include dry mouth, abnormally large pupils, urinary retention, constipation, den a fast heart rate.[1] E generally no for be used insyd people plus closed-angle glaucoma.[1] While der be no evidence say ein use during pregnancy dey cause birth defects, dis no be well studied so sound clinical judgment for be used.[5] E be likely safe during breastfeeding.[5] E be an antimuscarinic (a type of anticholinergic) wey dey work by inhibiting de parasympathetic nervous system.[1]

Atropine dey occur naturally insyd a number of plants of de nightshade family, wey dey include deadly nightshade (Atropa belladonna), jimsonweed (Datura stramonium), mandrake (Mandragora officinarum)[6] den angel's trumpet (Brugmansia).[7] Na atropine first be isolated insyd 1833.[8] E dey on de World Health Organization's List of Essential Medicines.[9] E be available as a generic medication.[1][10][11]

References

[edit | edit source]
  1. 1 2 3 4 5 6 7 "Atropine". The American Society of Health-System Pharmacists. Archived from the original on 12 July 2015. Retrieved 13 August 2015.
  2. ↑ Hamilton RJ, Duffy AN, Stone D, Spencer A (2014). Tarascon pharmacopoeia (15 ed.). Jones & Bartlett Publishers. p. 386. ISBN 978-1-284-05671-6. Archived from the original on 2 October 2015.
  3. ↑ "Amblyopia (Lazy Eye)". National Eye Institute. 2 July 2019. Archived from the original on 31 January 2020. Retrieved 31 January 2020. Putting special eye drops in the stronger eye. A once-a-day drop of the drug atropine can temporarily blur near vision, which forces the brain to use the other eye. For some children, this treatment works as well as an eye patch, and some parents find it easier to use (for example, because young children may try to pull off eye patches).
  4. ↑ Barash PG (2009). Clinical anesthesia (6th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. p. 525. ISBN 978-0-7817-8763-5. Archived from the original on 24 November 2015.
  5. 1 2 "Atropine Pregnancy and Breastfeeding Warnings". Archived from the original on 6 September 2015. Retrieved 14 August 2015.
  6. ↑ Brust JC (2004). Neurological aspects of substance abuse (2 ed.). Philadelphia: Elsevier. p. 310. ISBN 978-0-7506-7313-6. Archived from the original on 2 October 2015.
  7. ↑ Kim Y, Kim J, Kim OJ, Kim WC (August 2014). "Intoxication by angel's trumpet: case report and literature review". BMC Research Notes. 7 553. doi:10.1186/1756-0500-7-553. PMC 4148940. PMID 25138632.
  8. ↑ Ainsworth S (2014). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. John Wiley & Sons. p. 94. ISBN 978-1-118-81959-3. Archived from the original on 2 October 2015.
  9. ↑ World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
  10. ↑ Hamilton RJ (2014). Tarascon pharmacopoeia (15 ed.). Jones & Bartlett Publishers. p. 386. ISBN 978-1-284-05671-6. Archived from the original on 2 October 2015.
  11. ↑ "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.
[edit | edit source]